Sinclair Pharma Ltd
http://www.sinclairpharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sinclair Pharma Ltd
US FDA's Delay In Acting On Moderna RSV Vaccine Adds To Growing List of User Fee Goal Misses
Administrative constraints adds Moderna’s mRNA-1345 to the recently increasing number of US FDA user fee goal date misses.
Sanofi’s $500m COVID-19 Deal Comes Four Years Too Late
But it rescues embattled Novavax.
Beyond CAR-Ts: Cell-Based Gene Therapy Sponsors Are ‘Branching Out,’ CBER’s Marks Says
As sponsors explore development in autoimmune and infectious diseases, plus a range of hematologic and solid tumors, manufacturing processes can be centralized or decentralized, but Marks says the FDA is ‘neutral’ on that decision.
A Job Well Done: AstraZeneca Bids Adieu To Vaxzevria As Demand Dries Up
The voluntary withdrawal of the license for the UK major's COVID-19 vaccine is due to a surplus of available updated jabs from other companies that target new variants and is not connected to the mis- and disinformation being peddled on the internet and elsewhere on very rare adverse events.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Huadong Medicine Ltd
- Biosurface Pharma AB
- Laboratoire ObvieLine
- AQTIS Medical BV
- IS Pharma plc
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice